Literature DB >> 30353130

Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations.

Jonathan A Hensel1, Vinayak Khattar1, Reading Ashton1, Selvarangan Ponnazhagan2.   

Abstract

The lack of consensus on bone marrow (BM) and splenic immune cell profiles in preclinical mouse strains complicates comparative analysis across different studies. Although studies have documented relative distribution of immune cells from peripheral blood in mice, similar studies for BM and spleen from naïve mice are lacking. In an effort to establish strain- and gender-specific benchmarks for distribution of various immune cell subtypes in these organs, we performed immunophenotypic analysis of BM cells and splenocytes from both genders of three commonly used murine strains (C57BL/6NCr, 129/SvHsd, and BALB/cAnNCr). Total neutrophils and splenic macrophages were significantly higher in C57BL/6NCr, whereas total B cells were lower. Within C57BL/6NCr female mice, BM B cells were elevated with respect to the males whereas splenic mDCs and splenic neutrophils were reduced. Within BALB/cAnNCr male mice, BM CD4+ Tregs were elevated with respect to the other strains. Furthermore, in male BALB/cAnNCr mice, NK cells were elevated with respect to the other strains in both BM and spleen. Splenic CD4+ Tregs and splenic CD8+ T cells were reduced in male BALB/c mice in comparison to female mice. Bone marrow CD4+ T cells and mDCs were significantly increased in 129/SvHsd whereas splenic CD8+ T cells were reduced. In general, males exhibited higher immature myeloid cells, macrophages, and NK cells. To our knowledge, this study provides a first attempt to systematically establish organ-specific benchmarks on immune cells in studies involving these mouse strains.

Entities:  

Mesh:

Year:  2018        PMID: 30353130      PMCID: PMC6524955          DOI: 10.1038/s41374-018-0137-1

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  82 in total

1.  Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.

Authors:  R J Rodgers; R Augar; N Berryman; C J Hansom; M L O'Mahony; R M Palmer; A Stevens; A J Tallett
Journal:  Psychopharmacology (Berl)       Date:  2006-06-27       Impact factor: 4.530

2.  Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis.

Authors:  Jennifer L Larson-Casey; Jessy S Deshane; Alan J Ryan; Victor J Thannickal; A Brent Carter
Journal:  Immunity       Date:  2016-02-23       Impact factor: 31.745

3.  Innate immune response in Th1- and Th2-dominant mouse strains.

Authors:  Hiroyuki Watanabe; Kousuke Numata; Takaaki Ito; Katsumasa Takagi; Akihiro Matsukawa
Journal:  Shock       Date:  2004-11       Impact factor: 3.454

Review 4.  Of lineage and legacy: the development of mammalian hematopoietic stem cells.

Authors:  Elaine Dzierzak; Nancy A Speck
Journal:  Nat Immunol       Date:  2008-02       Impact factor: 25.606

5.  Genetic differences among C57BL/6 substrains.

Authors:  Kazuyuki Mekada; Kuniya Abe; Ayumi Murakami; Satoe Nakamura; Hatsumi Nakata; Kazuo Moriwaki; Yuichi Obata; Atsushi Yoshiki
Journal:  Exp Anim       Date:  2009-04

6.  Genetic influence on immune phenotype revealed strain-specific variations in peripheral blood lineages.

Authors:  Stefka B Petkova; Rong Yuan; Shirng-Wern Tsaih; William Schott; Derry C Roopenian; Beverly Paigen
Journal:  Physiol Genomics       Date:  2008-06-10       Impact factor: 3.107

7.  Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production.

Authors:  Maud M Gueders; Genevieve Paulissen; Celine Crahay; Florence Quesada-Calvo; Jonathan Hacha; Chris Van Hove; Kurt Tournoy; Renaud Louis; Jean-Michel Foidart; Agnes Noël; Didier D Cataldo
Journal:  Inflamm Res       Date:  2009-06-09       Impact factor: 4.575

8.  Tumor induction in BALB/c female mice after fission neutron or gamma irradiation.

Authors:  R L Ullrich
Journal:  Radiat Res       Date:  1983-03       Impact factor: 2.841

9.  Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.

Authors:  Cara C Schafer; Yong Wang; Kenneth P Hough; Anandi Sawant; Stefan C Grant; Victor J Thannickal; Jaroslaw Zmijewski; Selvarangan Ponnazhagan; Jessy S Deshane
Journal:  Oncotarget       Date:  2016-11-15

10.  Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding.

Authors:  Nemanja Jovicic; Ilija Jeftic; Ivan Jovanovic; Gordana Radosavljevic; Nebojsa Arsenijevic; Miodrag L Lukic; Nada Pejnovic
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

View more
  19 in total

1.  Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC.

Authors:  Thomas E Bickett; Michael W Knitz; Miles Piper; Ayman J Oweida; Jacob Gadwa; Laurel B Darragh; Diemmy Nguyen; Shilpa Bhatia; Shiv Bhuvane; Andy V Phan; Benjamin Van Court; Sophia Corbo; Tiffany Pham; Alexander L Dent; Laurel Lenz; Sana D Karam
Journal:  Mol Ther       Date:  2021-11-15       Impact factor: 11.454

2.  Production of MHCII-expressing classical monocytes increases during aging in mice and humans.

Authors:  Pijus K Barman; Juliana E Shin; Sloan A Lewis; Seokjo Kang; Di Wu; Yizhou Wang; Xiaoming Yang; Prakash S Nagarkatti; Mitzi Nagarkatti; Ilhem Messaoudi; Bérénice A Benayoun; Helen S Goodridge
Journal:  Aging Cell       Date:  2022-08-30       Impact factor: 11.005

Review 3.  Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines.

Authors:  Hannah S Newton; Marina A Dobrovolskaia
Journal:  Adv Drug Deliv Rev       Date:  2022-04-09       Impact factor: 17.873

4.  Modification of Fecal Bacteria Counts and Blood Immune Cells in the Offspring of BALB/c and C57BL/6 Mice Obtained through Interstrain Mouse Embryo Transfer.

Authors:  Ekaterina A Litvinova; Galina V Kontsevaya; Elena N Kozhevnikova; Kseniya M Achasova; Ludmila A Gerlinskaya; Natalya A Feofanova; Mikhail P Moshkin
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-09       Impact factor: 1.232

5.  Epithelial membrane protein 2 (Emp2) modulates innate immune cell population recruitment at the maternal-fetal interface.

Authors:  Alison Chu; Su-Yin Kok; Jessica Tsui; Meng-Chin Lin; Brian Aguirre; Madhuri Wadehra
Journal:  J Reprod Immunol       Date:  2021-03-09       Impact factor: 3.993

6.  Distinct Tumor Microenvironments Are a Defining Feature of Strain-Specific CRISPR/Cas9-Induced MPNSTs.

Authors:  Amanda Scherer; Victoria R Stephens; Gavin R McGivney; Wade R Gutierrez; Emily A Laverty; Vickie Knepper-Adrian; Rebecca D Dodd
Journal:  Genes (Basel)       Date:  2020-05-23       Impact factor: 4.096

Review 7.  Mouse models for mesothelioma drug discovery and development.

Authors:  Kenneth P Seastedt; Nathanael Pruett; Chuong D Hoang
Journal:  Expert Opin Drug Discov       Date:  2020-12-31       Impact factor: 7.050

8.  Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity.

Authors:  Jonathan A Hensel; Vinayak Khattar; Reading Ashton; Selvarangan Ponnazhagan
Journal:  Mol Ther Oncolytics       Date:  2018-12-13       Impact factor: 7.200

9.  O-Polysaccharide Plays a Major Role on the Virulence and Immunostimulatory Potential of Aggregatibacter actinomycetemcomitans During Periodontal Infection.

Authors:  Gustavo Monasterio; Francisca Castillo; Jessica Astorga; Anilei Hoare; Claudia Terraza-Aguirre; Emilio A Cafferata; Eduardo J Villablanca; Rolando Vernal
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

10.  Bioengineering of LAB vector expressing Haemolysin co-regulated protein (Hcp): a strategic approach to control gut colonization of Campylobacter jejuni in a murine model.

Authors:  Chandan Gorain; Afruja Khan; Ankita Singh; Samiran Mondal; Amirul Islam Mallick
Journal:  Gut Pathog       Date:  2021-07-30       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.